Supplementary Materials and Methods and Supplementary Figure Legends from Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody–Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect

Abstract

<p>PDF - 117K, Supplementary materials and methods, figure legends for supplementary figures and table.</p>